Definium Therapeutics, Inc. (DFTX)

36.82 +0.09 (+0.25%) USD  |  NASDAQ  |  Sep 25, 12:34
More

Definium Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for DFTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Enliven Therapeutics, Inc. --
Cocrystal Pharma, Inc. --
CNBX Pharmaceuticals, Inc. --
GB Sciences, Inc. --
Arvinas, Inc. Upgrade